CENTENNIAL, Colo.--(BUSINESS WIRE)--LABS, Inc., a Centennial-based comprehensive, highly accredited specialized clinical reference testing laboratory, announced it has appointed Sarah Dennison, MBA, as Vice President of Commercial Operations. Based at LABS, Inc. Centennial headquarters, Dennison is responsible for leading the teams that provide strategic sales and marketing growth strategies. Her teams are known for both innovation and execution, and include commercial insight, customer and sales services, and marketing services.
"As we continue to expand our operation, it's imperative that we have in-depth commercial strength across all areas of the organization. Her experience and leadership qualities lend themselves well to our team realizing our ambitions"
Dennison has nearly two decades of multi-functional experience in the pharma, diagnostics and laboratory services industry, bringing commercial leadership and expertise to LABS, Inc. Prior to joining the company, she served in various scientific and commercial roles at GeneDx, Pathway Genomics, Quidel Corp., and Sequenom.
"As we continue to expand our operation, it's imperative that we have in-depth commercial strength across all areas of the organization. Her experience and leadership qualities lend themselves well to our team realizing our ambitions," said Todd Johnson, President and CEO. "Dennison has a clear passion for the life sciences industry and we are very excited to have her on the team and look forward to her contributions to our success."
Dennison has a Bachelor of Science degree in Chemistry from Covenant College. She also holds a Master of Business Administration from Point Loma Nazarene University.
About LABS, Inc.
Founded in 1978 as Immunological Associates of Denver, now known as LABS, Inc., LABS operates laboratories in Centennial, Colorado and Philadelphia, Pennsylvania. Each facility is independently certified, accredited, licensed or registered by numerous agencies that may include AABB, American Society of Histocompatibility and Immunogenetics (ASHI), the College of American Pathologists (CAP), Clinical Laboratory Improvement Amendments (CLIA), the U.S. Food and Drug Administration (FDA), International Organization of Standardization (ISO) and the states of California, Florida, Maryland, New York, Pennsylvania, Rhode Island and West Virginia. For more information about LABS, Inc., visit www.labs-inc.org.
Jessica O'Neale, 720-528-4722